Navigation Links
First head-to-head trials of once weekly Fosamax and Actonel therapies

The drug major Merck has launched the first two head-to-head clinical trials that compare the efficacy and tolerability of Fosamax (alendronate) once weekly 70mg and Actonel (risedronate) once-weekly 35mg. Fosamax and Actonel, both bisphosphonates indicated for the treatment of osteoporosis in post menopausal women are co-marketed by Aventis and Procter & Gamble through the Alliance for// Better Bone Health. The trial called FACTs(Fosamax Actonel Comparison Trials), is being sponsored by Merck as a US-based study, as well as an international study, each of which will examine approximately 800 post menopausal women with osteoporosis(defined by a bone mineral density (BMD) T-score of <=-2). The participants will be randomized in a one-to-one blinded fashion to either alendronate 70mg once weekly or risedronate 35mg once weekly. The trials will then evaluate and compare the effectiveness and tolerability of the 2 agents during 12 months of treatment in the post menopausal women with osteoporosis.


'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. WHO Declares Vietnam First Country to Control SARS
6. Russia Reports First SARS Case
7. Hope for First New Melanoma Treatment in Decades
8. First global SARS meet opens
9. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
10. Hyderabad To Have Asia’s First Catheter Making Uni
11. First telesurgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2018)... ... August 15, 2018 , ... Many people might desire ... to achieve it. That’s where a great new option comes in: Injectable filler, which ... Sonoa Au, MD of Advanced Dermatology P.C. , An increasingly popular option ...
(Date:8/15/2018)... ... August 15, 2018 , ... Nowadays, it’s fairly common ... in cleansers, moisturizers and serums are known to seep into your bloodstream and accumulate ... we all become more and more informed about the quality of our skincare products, ...
(Date:8/15/2018)... ... 2018 , ... On July 30, more than 250 people attended Calvary Hospital’s ... Club in Westchester County. The event raised over $300,000 for Calvary programs and services ... included a performance by mentalist and comedian Eric Dittelman, a live auction, silent auction ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... announced new leadership roles for healthcare executives Simon Frisch and Chris Weinstein, who ... respectively. They assume their roles at a time of tremendous growth for the ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... support organizations (DSO) with nearly 400 affiliated offices across 16 states, is pleased ... in San Diego, California. , Smile Brands will provide full-service administrative support to ...
Breaking Medicine News(10 mins):
(Date:8/11/2018)... ... August 10, 2018 , ... US Capital Global ... a $2 million seed funding round. Carepoynt is an emerging leader in the digital ... of a more rewarding and engaging healthcare ecosystem. , Headquartered in San Francisco, US ...
(Date:8/9/2018)... SAN LEANDRO, Calif (PRWEB) , ... August 09, 2018 , ... ... communicate and socialize with others. Given how widespread autism is, (approximately 1 in 68 ... autism cannot be “cured,” there are options to help teach a child with autism ...
(Date:8/7/2018)... ... 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First Year and a ... ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes at the FDA ... may have gotten hurt. , And Gottlieb is just getting started. , Mark the ...
Breaking Medicine Technology: